Polyarteritis nodosa is an unforeseen borderline paradoxical adverse reaction in a female patient with rheumatoid arthritis treated with tofacitinib
The paper describes the occurrence of polyarteritis nodosa in a patient with rheumatoid arthritis during treatment with tofacitinib. It considers the reasons why this condition should be regarded as an unforeseen borderline paradoxical adverse reaction.
Main Authors: | Yu. V. Muraviev, S. G. Radenska-Lopovok, V. V. Lebedeva, S. Yu. Alamankina |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2019-09-01
|
Series: | Современная ревматология |
Subjects: | |
Online Access: | https://mrj.ima-press.net/mrj/article/view/944 |
Similar Items
-
Classical polyarteritis nodosa in an infant
by: I. L. Alimova, et al.
Published: (2016-03-01) -
Possibilities for the use of tofacitinib in patients with COVID-19
by: A. V. Matveev, et al.
Published: (2020-10-01) -
Tofacitinib is a modern solution to the problem of resistant rheumatoid arthritis
by: I. V. Menshikova, et al.
Published: (2019-05-01) -
ERYTHEMA NODOSUM: VASCULITIS OR PANNICULITIS?
by: Boris Sergeyevich Belov, et al.
Published: (2009-09-01) -
Experience with tofacitinib in the treatment of resistant rheumatoid arthritis
by: A. R. Babaeva, et al.
Published: (2015-06-01)